We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$9.68B
AUM Growth
+$282M
Cap. Flow
+$368M
Cap. Flow %
3.8%
Top 10 Hldgs %
10.65%
Holding
2,698
New
807
Increased
606
Reduced
561
Closed
588

Top Buys

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$110M
2
WTW icon
Willis Towers Watson
WTW
+$70.4M
3
GEN icon
Gen Digital
GEN
+$63.3M
4
GS icon
Goldman Sachs
GS
+$53.6M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$51.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$110M
2
META icon
Meta Platforms (Facebook)
META
+$72.2M
3
GPN icon
Global Payments
GPN
+$43.3M
4
CAH icon
Cardinal Health
CAH
+$41.2M
5
BNY
Bank of New York Mellon
BNY
+$40.3M

Sector Composition

Rank Sector Weight
1 Financials 27.55%
2 Technology 14.73%
3 Healthcare 8.47%
4 Consumer Discretionary 7.67%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNV icon
1001
Franco-Nevada
FNV
$44.6B
$897K 0.01%
6,900
+3,950
+134% +$579K
QS icon
1002
QuantumScape Corp
QS
$3.4B
$894K 0.01%
+36,400
New +$831K
EXE
1003
Expand Energy Corp
EXE
$21.3B
$893K 0.01%
+14,500
New +$813K
MCK icon
1004
McKesson
MCK
$102B
$892K 0.01%
4,475
-56,258
-93% -$11.2M
EBACU
1005
DELISTED
European Biotech Acquisition Corp. Units
EBACU
$888K 0.01%
89,475
-27,018
-23% -$268K
WARR
1006
DELISTED
Warrior Technologies Acquisition Company
WARR
$886K 0.01%
+90,296
New +$879K
MTZ icon
1007
MasTec
MTZ
$20.8B
$883K 0.01%
+10,236
New +$971K
HAYW icon
1008
Hayward Holdings
HAYW
$3.32B
$874K 0.01%
+39,316
New +$884K
CELL
1009
DELISTED
PhenomeX Inc. Common Stock
CELL
$874K 0.01%
+44,700
New +$1.7M
RARE icon
1010
Ultragenyx Pharmaceutical
RARE
$2.55B
$872K 0.01%
9,670
+7,353
+317% +$665K
RADI
1011
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$870K 0.01%
53,297
-55,570
-51% -$893K
JNCE
1012
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$867K 0.01%
116,784
-13,228
-10% -$81.9K
NKLA
1013
DELISTED
Nikola Corporation Common Stock
NKLA
$865K 0.01%
+2,703
New +$946K
ARCH
1014
DELISTED
Arch Resources, Inc.
ARCH
$863K 0.01%
9,300
-745
-7% -$52.3K
EDTX
1015
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$860K 0.01%
86,202
– –
WPM icon
1016
Wheaton Precious Metals
WPM
$56.9B
$859K 0.01%
22,853
+18,003
+371% +$785K
IIAC
1017
DELISTED
Investindustrial Acquisition Corp.
IIAC
$855K 0.01%
86,120
+53,861
+167% +$533K
GPGI
1018
GPGI Inc
GPGI
$4.34B
$854K 0.01%
101,720
+21,897
+27% +$184K
BBIO icon
1019
BridgeBio Pharma
BBIO
$16.2B
$853K 0.01%
18,200
-28,687
-61% -$1.54M
KURA icon
1020
Kura Oncology
KURA
$824M
$852K 0.01%
45,500
-43,500
-49% -$820K
PCPC
1021
DELISTED
Periphas Capital Partnering Corporation
PCPC
$852K 0.01%
35,000
+6,963
+25% +$169K
DCTH icon
1022
Delcath Systems
DCTH
$534M
$851K 0.01%
81,600
-5,200
-6% -$51.3K
RCUS icon
1023
Arcus Biosciences
RCUS
$3.61B
$851K 0.01%
+24,400
New +$759K
PMGMU
1024
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$851K 0.01%
85,743
– –
KAHC
1025
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$851K 0.01%
87,244
+36,964
+74% +$360K
39 40
41
42 43

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Schonfeld Strategic Advisors held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Schonfeld Strategic Advisors deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
  • Schonfeld Strategic Advisors added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
  • Schonfeld Strategic Advisors fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
  • Schonfeld Strategic Advisors opened 807 new positions and closed 588 in Q3 2021.
  • Schonfeld Strategic Advisors's portfolio value rose 3% quarter-over-quarter to $9.68B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.